PONY Q1 2026 Earnings Narrower Loss Per ADS Drives Positive Investor Sentiment Sensei Biotherapeutics Inc SNSE Q1 2026 Earnings Deep EPS Miss Reflects Heavy RD Investment and PreRevenue Status WMB Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Stock Edges Higher SION Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Navigates Pipeline Progress PureCycle Technologies Q1 2026 Earnings Narrowed Loss Beats Estimates as Stock Surges 84 Traws Pharma Q1 2026 Earnings Narrowed Loss Surpasses Expectations Amid PreRevenue Stage